Abstract
Introduction

Stem cells have been touted as potential therapeutic agents for a wide spectrum of degenerative diseases from Parkinson's disease to lysosomal storage diseases. In recent years, extra-embryonic tissue, such as placenta
and umbilical cord [3] [4] [5] [6] [8, 9] .
Recently, we have used a tissue explant method to isolate a stem cell population from the rat amniotic membrane, termed ADSCs. [10] . Differentiated 
ADSCs are capable of extensive self-renewal and exist in culture in a multi-differentiated state, expressing neuroectodermal (nestin), mesodermal (vimentin and fibronectin) and endodermal (␣-1-antitrypsin) genes. In vitro, ADSCs differentiate into presumptive fat, bone and liver cells. In addition, ADSCs differentiate into putative neural cells in vitro after culture in a defined neural induction media
Material and methods
Animal welfare
Animal studies were performed in accordance with guidelines established by the Institutional Animal Care and Use Committee at UMDNJ-RWJMS.
Reagents
All products were obtained from Sigma-Aldrich unless otherwise stated.
ADSC isolation and culture
ADSCs were isolated and cultured as previously described [10] . Briefly 
Generation of clonal lines
Clonal lines were generated from single cells as previously described [10, 16] 
Neural Induction
Neuronal differentiation was performed as previously described [17] 
Reporter vector construction and transfection into ADSCs
Transuterine intraventricular injection
Results
In vitro characterization of ADSCs
For transplantation studies we utilized a clonal population of ADSCs which uniformly expressed GFP (Fig. 1A-C) . This clonal population demonstrated the stem cell characteristics of selfrenewal and multi-potency, including the ability to differentiate into neuron-like cells in vitro [10] . Close to 100% of the cells expressed vimentin (Fig. 1D-G) , while a subset expressed the neural progenitor marker nestin. (Fig. 1H-K, arrowheads) . Overexpression of the GFP gene did not affect the cells ability to respond morphologically to the in vitro neural induction protocol (Fig. 1L) . Fig. 2A) . Some cells could also be identified within the parenchymal of the brain at this early time point (Fig. 2A, inset) . By E17.5, discrete spherical clusters consisting of GFP+ cells were observed within the ventricles (Fig. 2B, arrow) . A few clusters appeared to have fused with the walls of the ventricles (Fig. 2C) and individual donor cells could be seen in the brain parenchyma (Fig. 2C, 
Transplantation of GFP-expressing ADSCs into the embryonic brain
arrows). Widespread distribution of transplanted ADSCs was detected at later time points.
At E20.5, donor cells were consistently observed in multiple brain areas, including the cortex (Fig. 3A-C, arrow) and midbrain (Fig. 3D-F 
, arrow). Distribution of GFP + cells at later postnatal time points seemed to be random-varying from animal to animal. In some animals cells could be localized to the hippocampus and striatum while in others they were observed in the thalamus (data not shown).
Phenotypic characterization of transplanted ADSCs
The majority of donor cells that migrated into the parenchyma by P7, or 1 week postnatally, did not integrate within the normal cytoarchitecture of the brain. In most cases, the ADSCs assumed
Fig. 2 Infused ADSCs dispersed throughout the embryonic ventricular system and formed discrete spheres. (A) Sagittal section revealed extensive diffusion of donor ADSCs (arrow) throughout the ventricular system at E16.5 (24 hrs post-transplantation). (A, inset, arrow) Some donor cells were observed within the parenchyma of the brain even at this early time point. (B) By E17.5 donor cells formed discrete GFP + spheres or clusters (arrow) within the lateral ventricles. (C) Some spheres appeared to have fused with the walls of the ventricular cavity. Individual cells (arrows) could be observed migrating into the parenchyma. LV = lateral ventricle, *= cortex. Scale bars:
A, B = 100 m; A-inset = 20 m; C = 50 m either elongated (Fig. 4A, arrows) or ameboid (Fig. 4E, arrows) morphologies. Mirroring the expression pattern in culture, the majority of ADSC expressed vimentin (Fig. 4A-D, arrows) , while a subset also expressed Nestin (Fig. 4E-H, Fig  5A-C, (Fig. 5D-G, arrows) and GFAP (Fig. 5H-K 
arrows). Interestingly, a sub-population of cells that migrated around blood vessels attained crescent morphologies and expressed vWF (Fig. 4I-L, arrow), a blood glycoprotein involved in coagulation. These morphologic and phenotypic observations are consistent with an endothelial cell differentiation of donor ADSCs. None of the examined cells showed evidence of multiple nuclei, suggesting that fusion with endogenous cells did not contribute to donor cell survival or differentiation. Some ADSCs that engrafted in the brain did attain neuronal morphologies-small cell body with long process extensions (
arrow). Despite these morphological changes, no donor cells were found to up-regulate any neural or glial markers, including b-III-Tubulin
, arrows). Transplanted ADSCs were also negative for the mature neural markers MAP2, NeuN and the oligodendrocyte marker APC (data not shown).
Long-term survival of donor cells
Even in the absence of neuronal differentiation, donor ADSCs were able to survive in cortical (Fig. 6A-C, arrows) and vascular regions (Fig. 6D, arrow) 
up to two and half months postnatally, the longest time examined. No evidence of a host inflammatory response or immunological rejection was observed, at early (P7) or later postnatal time points, as indicated by the absence of ED1
+ reactive microglia cells (Fig. 6E-H) .
Discussion Overview
We have previously described the characterization of a stem cell population isolated from the rat amniotic membrane [10] . These 
ADSCs are able to undergo extensive self-renewal and differentiate in vitro into cells representing all germinal layers, including the neuroectoderm. In this report we characterize these cells after transplantation into the embryonic brain at a time when active neurogenesis is occurring.
Donor ADSCs in the embryonic brain: sphere formation, invasion and migration
Numerous studies have demonstrated the feasibility of using the developing brain as a tool for assessing stem cells plasticity in vivo [11] [12] [13] [14] [15] [18] [19] [20] [21] [22] [23] . This effect does not seem to be limited to the brain; functional improvement in the absence of differentiation has been reported in animal models of diabetes, lung and cardiovascular disease [23] [24] [25] [26] .
ADSC differentiation and long-term survival
The long-term expression of transfected GFP in donor cells suggests that genetically modified ADSCs may be useful for 
